MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
9.28
+0.62 (7.16%)
At close: Oct 7, 2025, 4:00 PM EDT
9.25
-0.03 (-0.32%)
After-hours: Oct 7, 2025, 6:57 PM EDT

MLTX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21
5893,4153,620409-
Market Cap Growth
-82.55%-5.66%784.47%--
Enterprise Value
2472,9323,189353-
Last Close Price
8.6654.1560.3910.509.89
PB Ratio
1.557.537.055.95-
P/TBV Ratio
1.697.647.308.37-
Debt / Equity Ratio
0.210.010.010.00-1.29
Quick Ratio
15.6620.0751.389.440.39
Current Ratio
16.6521.1151.599.980.46
Return on Equity (ROE)
-40.34%-25.08%-15.14%-225.86%-
Return on Assets (ROA)
-24.98%-17.81%-11.21%-93.99%-
Return on Capital (ROIC)
-25.96%-18.38%-11.54%-112.32%-
Earnings Yield
-29.54%-3.48%-1.00%-12.21%-
FCF Yield
-27.97%-3.43%-1.19%-13.66%-
Buyback Yield / Dilution
-5.56%-27.99%-67.30%-274.47%-
Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q